These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 10205231

  • 1. Effects of candesartan and cilazapril on rats with myocardial infarction assessed by echocardiography.
    Yoshiyama M, Takeuchi K, Omura T, Kim S, Yamagishi H, Toda I, Teragaki M, Akioka K, Iwao H, Yoshikawa J.
    Hypertension; 1999 Apr; 33(4):961-8. PubMed ID: 10205231
    [Abstract] [Full Text] [Related]

  • 2. Angiotensin II type 1-receptor antagonist candesartan cilexitil prevents left ventricular dysfunction in myocardial infarcted rats.
    Hanatani A, Yoshiyama M, Takeuchi K, Kim S, Nakayama K, Omura T, Iwao H, Yoshikawa J.
    Jpn J Pharmacol; 1998 Sep; 78(1):45-54. PubMed ID: 9804061
    [Abstract] [Full Text] [Related]

  • 3. Effect of cilazapril on ventricular remodeling assessed by Doppler-echocardiographic assessment and cardiac gene expression.
    Yoshiyama M, Takeuchi K, Hanatani A, Shimada T, Takemoto Y, Shimizu N, Omura T, Kim S, Iwao H, Yoshikawa J.
    Cardiovasc Drugs Ther; 1998 Mar; 12(1):57-70. PubMed ID: 9607133
    [Abstract] [Full Text] [Related]

  • 4. Angiotensin blockade inhibits osteopontin expression in non-infarcted myocardium after myocardial infarction.
    Kusuyama T, Yoshiyama M, Omura T, Nishiya D, Enomoto S, Matsumoto R, Izumi Y, Akioka K, Takeuchi K, Iwao H, Yoshikawa J.
    J Pharmacol Sci; 2005 Jul; 98(3):283-9. PubMed ID: 15997171
    [Abstract] [Full Text] [Related]

  • 5. Differences in time course of myocardial mRNA expression in non-infarcted myocardium after myocardial infarction.
    Omura T, Yoshiyama M, Takeuchi K, Hanatani A, Kim S, Yoshida K, Izumi Y, Iwao H, Yoshikawa J.
    Basic Res Cardiol; 2000 Aug; 95(4):316-23. PubMed ID: 11005587
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Inhibition by angiotensin II type 1 receptor antagonist of cardiac phenotypic modulation after myocardial infarction.
    Hanatani A, Yoshiyama M, Kim S, Omura T, Toda I, Akioka K, Teragaki M, Takeuchi K, Iwao H, Takeda T.
    J Mol Cell Cardiol; 1995 Sep; 27(9):1905-14. PubMed ID: 8523451
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Doppler echocardiographic assessment and cardiac gene expression analysis of the left ventricle in myocardial infarcted rats.
    Shimizu N, Yoshiyama M, Takeuchi K, Hanatani A, Kim S, Omura T, Iwao H, Yoshikawa J.
    Jpn Circ J; 1998 Jun; 62(6):436-42. PubMed ID: 9652320
    [Abstract] [Full Text] [Related]

  • 12. Beneficial effects of combination of ACE inhibitor and angiotensin II type 1 receptor blocker on cardiac remodeling in rat myocardial infarction.
    Nakamura Y, Yoshiyama M, Omura T, Yoshida K, Izumi Y, Takeuchi K, Kim S, Iwao H, Yoshikawa J.
    Cardiovasc Res; 2003 Jan; 57(1):48-54. PubMed ID: 12504813
    [Abstract] [Full Text] [Related]

  • 13. Cardiovascular effects of combination of perindopril, candesartan, and amlodipine in hypertensive rats.
    Kim S, Zhan Y, Izumi Y, Iwao H.
    Hypertension; 2000 Mar; 35(3):769-74. PubMed ID: 10720593
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Renin-angiotensin system and myocardial collagen matrix: modulation of cardiac fibroblast function by angiotensin II type 1 receptor antagonism.
    Brilla CG, Scheer C, Rupp H.
    J Hypertens Suppl; 1997 Dec; 15(6):S13-9. PubMed ID: 9493122
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Angiotensin type 1 receptor antagonism with irbesartan inhibits ventricular hypertrophy and improves diastolic function in the remodeling post-myocardial infarction ventricle.
    Ambrose J, Pribnow DG, Giraud GD, Perkins KD, Muldoon L, Greenberg BH.
    J Cardiovasc Pharmacol; 1999 Mar; 33(3):433-9. PubMed ID: 10069680
    [Abstract] [Full Text] [Related]

  • 19. Ventricular remodeling and transforming growth factor-beta 1 mRNA expression after nontransmural myocardial infarction in rats: effects of angiotensin converting enzyme inhibition and angiotensin II type 1 receptor blockade.
    Youn TJ, Kim HS, Oh BH.
    Basic Res Cardiol; 1999 Aug; 94(4):246-53. PubMed ID: 10505424
    [Abstract] [Full Text] [Related]

  • 20. Combination treatment with a calcium channel blocker and an angiotensin blocker in a rat systolic heart failure model with hypertension.
    Namba M, Kim S, Zhan Y, Nakao T, Iwao H.
    Hypertens Res; 2002 May; 25(3):461-6. PubMed ID: 12135327
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.